DHR vs PYPL: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and PayPal Holdings, Inc. β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Danaher Corporation Β· Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
PayPal Holdings, Inc. Β· Financial Services
$42.51
+45.0% upside to fair value
Grade B
QuantHub Verdict
PYPL has more upside to fair value
(+45.0%).
PYPL trades at a lower forward P/E
(7.7x).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
DHR |
PYPL |
| Current Price |
$195.98 |
$42.51 |
| Fair Value Estimate |
$211.54 |
$61.64 |
| Upside to Fair Value |
+7.9%
|
+45.0%
|
| Market Cap |
$138.7B |
$37.5B |
| Forward P/E |
37.8x
|
7.7x
|
| EV / EBITDA |
22.8x
|
5.3x
|
| Price / Sales |
5.6x
|
1.1x
|
| Price / FCF |
26.2x
|
6.8x
|
| Revenue Growth YoY |
+3.7%
|
+7.2%
|
| Gross Margin |
60.7%
|
46.1%
|
| Operating Margin |
21.0%
|
17.9%
|
| Return on Equity |
7.1%
|
25.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
14.71%
|
| Analyst Consensus |
Strong Buy
|
Sell
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in theβ¦
PayPal Holdings, Inc. operates as a leading global digital payments platform with a competitive moat driven by its extensive network effects, brand recognition, and scale. Despite a durable business model with 2025 revenue of $33.17 billion growing at 4.3% year-over-year and a strong return on equity of 25.1%, the company faces slowing growth and margin pressures, reflected in a 13.5% decline in β¦
Accumulation Zones
| Metric |
DHR |
PYPL |
| Zone Low |
$158.66 |
$46.23 |
| Zone High |
$179.81 |
$52.39 |
| In Buy Zone? |
No
|
Yes
|